ID1 Promotes Hepatocellular Carcinoma Proliferation and Confers Chemoresistance to Oxaliplatin by Activating Pentose Phosphate Pathway

Xin Yin,Bei Tang,Jing-Huan Li,Yan Wang,Lan Zhang,Xiao-Ying Xie,Bo-Heng Zhang,Shuang-Jian Qiu,Wei-Zhong Wu,Zheng-Gang Ren
DOI: https://doi.org/10.1186/s13046-017-0637-7
IF: 12.658
2017-01-01
Journal of Experimental & Clinical Cancer Research
Abstract:Drug resistance is one of the major concerns in the treatment of hepatocellular carcinoma (HCC). The aim of the present study was to determine whether aberrant high expression of the inhibitor of differentiation 1(ID1) confers oxaliplatin-resistance to HCC by activating the pentose phosphate pathway (PPP).
What problem does this paper attempt to address?